These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 17702724

  • 1. Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study.
    Franciosi M, Pellegrini F, Sacco M, De Berardis G, Rossi MC, Strippoli GF, Belfiglio M, Tognoni G, Valentini M, Nicolucci A, IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group.
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):984-91. PubMed ID: 17702724
    [Abstract] [Full Text] [Related]

  • 2. The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China.
    Chen B, Yang D, Chen Y, Xu W, Ye B, Ni Z.
    Clin Chim Acta; 2010 May 02; 411(9-10):705-9. PubMed ID: 20138167
    [Abstract] [Full Text] [Related]

  • 3. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality.
    Klausen KP, Parving HH, Scharling H, Jensen JS.
    J Intern Med; 2007 Oct 02; 262(4):470-8. PubMed ID: 17875184
    [Abstract] [Full Text] [Related]

  • 4. Microalbuminuria and the metabolic syndrome and its components in the Chinese population.
    Lin CC, Liu CS, Li TC, Chen CC, Li CI, Lin WY.
    Eur J Clin Invest; 2007 Oct 02; 37(10):783-90. PubMed ID: 17888089
    [Abstract] [Full Text] [Related]

  • 5. A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS).
    Bello AK, Peters J, Wight J, de Zeeuw D, El Nahas M, European Kidney Institute.
    Am J Kidney Dis; 2008 Sep 02; 52(3):434-43. PubMed ID: 18725014
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of microalbuminuria in non-diabetic hypertensive patients attended by Portuguese GPs.
    Polónia J, Carmona J, Mendes E, Pisco L.
    Rev Port Cardiol; 2007 Jun 02; 26(6):637-44. PubMed ID: 17849947
    [Abstract] [Full Text] [Related]

  • 7. Microalbuminuria in treated hypertensives: only a mirror image of cardiovascular risk? The HUNT Study, Norway.
    Kvenild K, Romundstad S, Midthjell K, Krüger O, Hallan H, Holmen J.
    Scand J Prim Health Care; 2006 Sep 02; 24(3):145-53. PubMed ID: 16923623
    [Abstract] [Full Text] [Related]

  • 8. Microalbuminuria and metabolic risk factors in patients with type 2 diabetes in primary care setting in Thailand.
    Aekplakorn W, Srivanichakorn S, Sangwatanaroj S.
    Diabetes Res Clin Pract; 2009 Apr 02; 84(1):92-8. PubMed ID: 19168252
    [Abstract] [Full Text] [Related]

  • 9. Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients.
    Rodilla E, Pérez-Lahiguera F, Costa JA, González C, Miralles A, Moral D, Pascual JM.
    Med Clin (Barc); 2009 Jan 17; 132(1):1-6. PubMed ID: 19174057
    [Abstract] [Full Text] [Related]

  • 10. Association of metabolic syndrome with microalbuminuria in non-hypertensive type 2 diabetic patients.
    Lee JE, Huh W, Son HJ, Kim YG, Kim DJ, Lee MK, Oh HY.
    Nephron Clin Pract; 2007 Jan 17; 106(3):c98-103. PubMed ID: 17522477
    [Abstract] [Full Text] [Related]

  • 11. Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: immunonephelometry compared with high-performance liquid chromatography.
    Polkinghorne KR, Su Q, Chadban SJ, Shaw JE, Zimmet PZ, Atkins RC.
    Am J Kidney Dis; 2006 Apr 17; 47(4):604-13. PubMed ID: 16564938
    [Abstract] [Full Text] [Related]

  • 12. Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction.
    Marquezine GF, Oliveira CM, Pereira AC, Krieger JE, Mill JG.
    Int J Cardiol; 2008 Sep 26; 129(2):259-65. PubMed ID: 18036678
    [Abstract] [Full Text] [Related]

  • 13. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M, Cortez-Dias N, Martins S, Belo A, VALSIM study investigators.
    Rev Port Cardiol; 2008 Dec 26; 27(12):1495-529. PubMed ID: 19280993
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
    Bleyer AJ, Sedor JR, Freedman BI, O'Brien A, Russell GB, Graley J, Schelling JR.
    Am J Kidney Dis; 2008 Jan 26; 51(1):29-37. PubMed ID: 18155530
    [Abstract] [Full Text] [Related]

  • 15. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M, Saavedra P, Varillas VF, Wagner AM, López-Plasencia Y, Alberiche MP, Nóvoa FJ.
    Nutr Metab Cardiovasc Dis; 2009 Jul 26; 19(6):417-22. PubMed ID: 18819785
    [Abstract] [Full Text] [Related]

  • 16. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension?
    Muxfeldt ES, Salles GF.
    J Hypertens; 2008 May 26; 26(5):878-84. PubMed ID: 18398329
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population.
    Strazzullo P, Barbato A, Siani A, Cappuccio FP, Versiero M, Schiattarella P, Russo O, Avallone S, della Valle E, Farinaro E.
    Metabolism; 2008 Mar 26; 57(3):355-61. PubMed ID: 18249207
    [Abstract] [Full Text] [Related]

  • 18. Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study.
    Böhm M, Thoenes M, Danchin N, Bramlage P, La Puerta P, Volpe M.
    J Hypertens; 2007 Nov 26; 25(11):2317-24. PubMed ID: 17921828
    [Abstract] [Full Text] [Related]

  • 19. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM, Wat NM, Man YB, Tam S, Cheng CH, Leung GM, Woo J, Janus ED, Lau CP, Lam TH, Lam KS.
    Am J Hypertens; 2008 Jan 26; 21(1):17-22. PubMed ID: 18091739
    [Abstract] [Full Text] [Related]

  • 20. Microalbuminuria associated with systolic blood pressure and arterial compliance in Chinese metabolic syndrome patients.
    Li XL, Xu Q, Tong M, Lu XZ, Zhang HF, Zhou YL, Cao KJ, Huang J.
    Chin Med J (Engl); 2007 Aug 20; 120(16):1395-9. PubMed ID: 17825166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.